Supplement formulation case study

Dr. VR Wellness used Formulaite to build and model a supplement formula now in clinical trials.

Formulaite helped turn clinical literature into a supplement formulation, then Simulaite provided the mechanistic modeling layer underneath the program.

>$100KAlternative PK study cost avoided through in silico modeling.
Live trialCoordinated through Genelife Clinical Research.
Formula + PKClinical-literature formulation with Simulaite modeling.
Dr. VR Wellness case study image for supplement formulation acceleration

At a glance

  • Dr. VR Wellness used Formulaite to develop a clinical-literature-backed supplement formula.
  • Simulaite then provided mechanistic and in silico pharmacokinetic technical support for that formula.
  • The program is now in clinical trials led by Dr. Vinod Kumar Rustgi through Genelife Clinical Research.
  • More than $100K in alternative pharmacokinetic study cost was avoided with in silico modeling while the program advanced into clinical trials.

The challenge

Dr. VR Wellness was not looking for a shortcut around clinical validation. The team was going above and beyond by moving the product into a clinical trial led by Dr. Vinod Kumar Rustgi through Genelife Clinical Research.

The challenge was earlier in the product-development stack: build the supplement formula from clinical literature, choose actives with a clear rationale, and create a mechanistic support package without also spending six figures on a separate pharmacokinetic study path.

How Formulaite worked with Dr. VR Wellness

The Dr. VR Wellness team led the product vision. Formulaite helped translate clinical literature into the supplement formulation itself: candidate active reasoning, dose logic, endpoint fit, and the scientific rationale behind the product.

After the formulation work, Simulaite modeled the expected exposure profile, pharmacological behavior at the proposed dose, and mechanistic rationale for the endpoint being pursued in the trial. That in silico output helped the team avoid the separate PK study path while still investing in the clinical trial itself.

Why it mattered

Formulaite supported both sides of the scientific package: the clinical-literature-based supplement formulation and the Simulaite modeling layer. That let Dr. VR Wellness avoid the cost of a separate PK study route while still investing in the clinical trial as the higher standard of evidence.

The collaboration also fit the scientific frame of Dr. Vinod Kumar Rustgi, whose published work spans hepatology, AI and machine learning applications in liver disease, and computational approaches to disease modeling.

What to know

Dr. VR Wellness is investing in a live clinical trial for the product. Formulaite helped build the literature-backed supplement formula and used Simulaite to provide the in silico pharmacokinetic evidence that avoided a separate six-figure PK study path.

More context

Clinical investigator context

Dr. Vinod Kumar Rustgi is a hepatology leader at Rutgers Robert Wood Johnson Medical School, where his work spans liver disease, hepatology, and computational approaches to disease modeling. His background makes the program a strong fit for a formulation workflow that combines clinical literature reasoning with mechanistic simulation.

The clinical trial is coordinated through Genelife Clinical Research, a CDSCO-registered CRO with clinical research, bioavailability, bioequivalence, medical writing, biostatistics, pharmacovigilance, and regulatory affairs capabilities.

How Formulaite helped build the formula

Formulaite helped the Dr. VR Wellness team turn clinical literature into formulation decisions. That included reasoning through candidate actives, dose logic, endpoint fit, and the scientific rationale behind the product before the program moved deeper into clinical validation.

Formulaite supported the formulation design layer and then used Simulaite to model the formula, giving the team the exposure and mechanism layer underneath the clinical program.

Why the simulation mattered

Simulaite modeled the formulation's expected exposure profile, pharmacological behavior at the proposed dose, and mechanistic rationale for the endpoint being pursued. That output helped avoid a separate pharmacokinetic study route that would otherwise have added six-figure cost.

Dr. VR Wellness still moved forward with clinical validation. The modeling helped de-risk and support the product-development package while the team preserved budget for the clinical trial itself.